Insulin glargine, recombinant Subcutaneous and Spiriva
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Spiriva and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: tiotropium
Brand name: Spiriva Handihaler, Spiriva Respimat, Spiriva, Spiriva Respimat 30 Dose, Spiriva Respimat 14 Dose, Spiriva Respimat 28 ACT, Spiriva Respimat 60 ACT, Spiriva Respimat 10 ACT
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Spiriva Handihaler
- Insulin glargine, recombinant Subcutaneous-Spiriva Respimat
- Insulin glargine, recombinant Subcutaneous-Spironolactone
- Insulin glargine, recombinant Subcutaneous-Spironolactone and hydrochlorothiazide
- Insulin glargine, recombinant Subcutaneous-Spironolactone Oral Suspension
- Insulin glargine, recombinant Subcutaneous-Spironolactone Tablets
- Spiriva-Insulin glulisine
- Spiriva-Insulin Glulisine (Cartridges and Pens)
- Spiriva-Insulin Glulisine (Vials)
- Spiriva-Insulin glulisine Subcutaneous
- Spiriva-Insulin human inhaled Inhalation
- Spiriva-Insulin human regular Injection